Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DBH | P09172 | 3/20 | 1.00 |
| ▸ | MMP2 | P08253 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.53 |
| ▸ | RECQL | P46063 | 3/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | EGFR | P00533 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | FYN | P06241 | 2/20 | 0.53 |
| ▸ | MMP9 | P14780 | 2/20 | 0.53 |
| ▸ | CDK2 | P24941 | 2/20 | 0.53 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | MMP8 | P22894 | 1/20 | 0.53 |
| ▸ | CA6 | P23280 | 1/20 | 0.53 |
| ▸ | MMP12 | P39900 | 1/20 | 0.53 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL524707 | 0.86 | DBH (1.00) | DBHMMP2TDP1ALDH1A1HPGD | |
| Tropolone SCHEMBL42739 | 0.79 | — | — | |
| Tropolone SCHEMBL9643338 | 0.77 | DBH (0.94) | DBHMMP2TDP1ALDH1A1HPGD | |
| Tropolone SCHEMBL5969452 | 0.77 | DBH (0.94) | DBHMMP2TDP1ALDH1A1HPGD | |
| Tropolone SCHEMBL29029471 | 0.77 | DBH (0.94) | DBHMMP2TDP1ALDH1A1HPGD | |
| Tropolone SCHEMBL9643396 | 0.77 | DBH (0.94) | DBHMMP2TDP1ALDH1A1HPGD | |
| Tropolone SCHEMBL531387 | 0.77 | DBH (0.94) | DBHMMP2TDP1ALDH1A1HPGD | |
| Tropolone SCHEMBL9644163 | 0.77 | DBH (0.94) | DBHMMP2TDP1ALDH1A1HPGD | |
| Tropolone SCHEMBL16910519 | 0.77 | DBH (0.94) | DBHMMP2TDP1ALDH1A1HPGD | |
| Tropolone SCHEMBL9644286 | 0.77 | DBH (0.94) | DBHMMP2TDP1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4021413-A1 | LIPOSOMAL TROPONOID COMPOUND FORMULATIONS | United States Government as Represented by The Department of Veterans Affairs (US) | 2022-07-06 | — | — | EP | claimed |
| WO-2021041776-A1 | LIPOSOMAL TROPONOID COMPOUND FORMULATIONS | UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) | 2021-03-04 | — | — | WO | claimed |
| WO-2019118803-A1 | CHEMICAL ENTITIES FOR LYTIC ACTIVATION OF KSHV AND THERAPEUTIC TARGETING OF VIRAL ENZYMES/PROTEINS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2019-06-20 | — | — | WO | claimed |
| EP-1976497-A2 | TREATMENT OF VIRAL INFECTIONS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2008-10-08 | — | — | EP | claimed |
| WO-2007065007-A9 | TREATMENT OF VIRAL INFECTIONS | US HEALTH (US) | 2007-09-13 | — | — | WO | claimed |
| WO-2007065007-A2 | TREATMENT OF VIRAL INFECTIONS | GOVERNMENT OF THE U.S.A., AS REPERSENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2007-06-07 | — | — | WO | claimed |
| WO-2019195181-A9 | ANTIBODIES AND FRAGMENTS THEREOF THAT BIND HEPATITIS B VIRUS PROTEIN X | GILEAD SCIENCES, INC. (US) | 2023-07-06 | — | — | WO | disclosed |
| US-11421223-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| EP-4021413-A1 | LIPOSOMAL TROPONOID COMPOUND FORMULATIONS | United States Government as Represented by The Department of Veterans Affairs (US) | 2022-07-06 | — | — | EP | disclosed |
| WO-2022087422-A9 | PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AND RELATED USES | CHULALONGKORN UNIVERSITY (TH) | 2022-06-09 | — | — | WO | disclosed |
| WO-2022087422-A1 | PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AND RELATED USES | CHULALONGKORN UNIVERSITY (TH) | 2022-04-28 | — | — | WO | disclosed |
| EP-3935065-A1 | 3'3'-CYCLIC DINUCLEOTIDE ANALOGUE COMPRISING A CYCLOPENTANYL MODIFIED NUCLEOTIDE AS STING MODULATOR | Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. (CZ) | 2022-01-12 | — | — | EP | disclosed |
| EP-3873608-A1 | SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS HAVING HPK1 INHIBITORY ACTIVITY | GILEAD SCIENCES, INC. (US) | 2021-09-08 | — | — | EP | disclosed |
| WO-2012013967-A2 | NEW USES | SYNTOPIX GROUP PLC (GB) | 2012-02-02 | — | — | WO | disclosed |
| EP-1976497-A2 | TREATMENT OF VIRAL INFECTIONS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2008-10-08 | — | — | EP | disclosed |
| CN-101044403-A | Methods for altering surface characteristics of microspheres | LUMINEX CORP (US) | 2007-09-26 | — | — | CN | disclosed |
| WO-2007065007-A9 | TREATMENT OF VIRAL INFECTIONS | US HEALTH (US) | 2007-09-13 | — | — | WO | disclosed |
| WO-2007065007-A2 | TREATMENT OF VIRAL INFECTIONS | GOVERNMENT OF THE U.S.A., AS REPERSENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2007-06-07 | — | — | WO | disclosed |
| US-4883758-A | Biologically pure culture of the microorganism Streptomycas tropolofaciens used for producing 3,7-dihydroxytropolone and antitumor use | BRISTOL-MYERS COMPANY (US) | 1989-11-28 | — | — | US | disclosed |
| US-4833079-A | CULTURE OF STREPTOMYCES | BRISTOL-MYERS COMPANY (US) | 1989-05-23 | — | — | US | disclosed |